World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
110
Citations
51585
World Ranking
5495
National Ranking
2962

Overview

Joseph F. Quinn is affiliated with Oregon Health & Science University in the United States. Their research primarily focuses on medicine, with a significant emphasis on neurology, physiology, molecular biology, psychiatry and mental health, and complementary and alternative medicine.

Their work covers several key topics, including:

  • Alzheimer's disease research and treatments
  • Parkinson's Disease mechanisms and treatments
  • Dementia and cognitive impairment research
  • Medicinal plants and neuroprotection
  • Neuroinflammation and neurodegeneration mechanisms
  • Cholinesterase and neurodegenerative diseases
  • Functional brain connectivity studies

Joseph F. Quinn has contributed to multiple high-profile publication venues. Their most frequent publication outlets include:

  • Alzheimer s & Dementia
  • Journal of Alzheimer s Disease
  • Nature Communications
  • Scientific Reports
  • bioRxiv (Cold Spring Harbor Laboratory)

Notable recent papers by Joseph F. Quinn include:

  • Spread of pathological tau proteins through communicating neurons in human Alzheimer's disease, 2020, Nature Communications
  • Functional brain architecture is associated with the rate of tau accumulation in Alzheimer's disease, 2020, Nature Communications
  • In vivo staging of regional amyloid deposition, 2022, Columbia Academic Commons (Columbia University)
  • Characterizing Heterogeneity in Neuroimaging, Cognition, Clinical Symptoms, and Genetics Among Patients With Late-Life Depression, 2022, JAMA Psychiatry
  • Challenges and Opportunities with Causal Discovery Algorithms: Application to Alzheimer's Pathophysiology, 2020, Scientific Reports

Research collaboration is evident in Quinn's work, with frequent co-authors including:

  • Jeffrey Kaye
  • John C. Morris
  • Betty Lind
  • Michael Donohue
  • Sara Dolen

Best Publications

  • Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.

    Adam C. Naj;Gyungah Jun;Gary W. Beecham;Li-San Wang

  • The ageing systemic milieu negatively regulates neurogenesis and cognitive function

    Saul A. Villeda;Jian Luo;Kira I. Mosher;Bende Zou

  • Analysis of shared heritability in common disorders of the brain

    Verneri Anttila;Verneri Anttila;Brendan Bulik-Sullivan;Brendan Bulik-Sullivan;Hilary K. Finucane;Raymond K. Walters;Raymond K. Walters

  • Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins

    Sandip Ray;Markus Britschgi;Charles Herbert;Yoshiko Takeda-Uchimura

  • Mitochondria are a direct site of Aβ accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression

    Maria Manczak;Thimmappa S. Anekonda;Edward Henson;Byung S. Park

  • Early role of vascular dysregulation on late-onset Alzheimer’s disease based on multifactorial data-driven analysis

    Y. Iturria-Medina;R. C. Sotero;P. J. Toussaint;J. M. Mateos-Pérez

  • Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

    Rebecca Sims;Sven J. Van Der Lee;Adam C. Naj;Céline Bellenguez;Céline Bellenguez

  • Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial.

    Joseph F. Quinn;Rema Raman;Ronald G. Thomas;Karin Yurko-Mauro

  • DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson's disease

    Zhen Hong;Min Shi;Kathryn A. Chung;Joseph F. Quinn

  • Four distinct trajectories of tau deposition identified in Alzheimer’s disease

    Jacob W Vogel;Alexandra L Young;Neil P Oxtoby;Ruben Smith

  • Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease

    Min Shi;Changqin Liu;Travis J. Cook;Kristin M. Bullock;Kristin M. Bullock

  • Association of Perivascular Localization of Aquaporin-4 With Cognition and Alzheimer Disease in Aging Brains.

    Douglas M. Zeppenfeld;Matthew Simon;J. Douglas Haswell;Daryl D’Abreo

  • Neuropathological and Genetic Correlates of Survival and Dementia Onset in Synucleinopathies: A Retrospective Analysis

    David J Irwin;Murray Grossman;Daniel Weintraub;Daniel Weintraub;Howard I Hurtig

  • Lipid peroxidation in aging brain and Alzheimer's disease.

    Thomas J Montine;M.Diana Neely;Joseph F Quinn;M.Flint Beal

  • Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression.

    Min Shi;Joshua Bradner;Aneeka M. Hancock;Kathryn A. Chung

  • YKL-40: A Novel Prognostic Fluid Biomarker for Preclinical Alzheimer's Disease

    Rebecca Craig-Schapiro;Richard J. Perrin;Catherine M. Roe;Chengjie Xiong

  • Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disorders

    Fadi Abdi;Joseph F. Quinn;Joseph Jankovic;Martin McIntosh

  • Cerebrospinal Fluid Tau and β-Amyloid: How Well Do These Biomarkers Reflect Autopsy-Confirmed Dementia Diagnoses?

    Christopher M. Clark;Sharon Xie;Jesse Chittams;Douglas Ewbank

  • Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease

    Alex E. Roher;Chera L. Esh;Tyler A. Kokjohn;Eduardo Miguel Castaño

  • Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease

    P. Hemachandra Reddy;Shannon McWeeney;Byung S. Park;Maria Manczak

Frequent Co-Authors

Jeffrey Kaye
Jeffrey Kaye Oregon Health & Science University
Thomas J. Montine
Thomas J. Montine Stanford University
Elaine R. Peskind
Elaine R. Peskind University of Washington
Cyrus P. Zabetian
Cyrus P. Zabetian University of Washington
Douglas Galasko
Douglas Galasko University of California, San Diego
James B. Leverenz
James B. Leverenz Cleveland Clinic
Christopher M. Clark
Christopher M. Clark University of Pennsylvania
Charles DeCarli
Charles DeCarli University of California, Davis
Paul S. Aisen
Paul S. Aisen University of Southern California
John C. Morris
John C. Morris Washington University in St. Louis

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medical careers in the USA goes beyond the traditional MD path. Many professionals are now advancing their expertise with flexible online options. For nurses looking to become nurse practitioners, rn to np programs online can offer a streamlined bridge, allowing experienced RNs to earn advanced degrees without pausing their careers.

Health and wellness careers are also on the rise. An online degree in nutrition equips graduates to work in settings from hospitals to fitness companies, all with the convenience of remote study. For those seeking healthcare leadership roles, enrolling in a cahme accredited online mha program ensures a quality education that meets industry standards.

Many online nursing degrees also reduce barriers, with options like rn to bsn programs no clinicals, allowing licensed RNs to further their education without additional clinical hours. These pathways make it easier for working healthcare professionals to balance growth and responsibilities while moving forward in their careers.

Best Scientists Citing Joseph F. Quinn

Trending Scientists

Recently Published Articles